Results 111 to 120 of about 31,992 (181)

Anti-hepatoma activity of taxol in vitro [PDF]

, 2000
AIM: To investigate the in vitro anti-hepatoma activity of taxol against SMMC-7721 human hepatoma cells. METHODS: The hepatoma cell growth was measured by MTT-microculture tetrazolium assay.
Luo, Dan, Wang, Xing Wang, Xie, Hong, Yuan, Jin Hui, Xie, Yong   +4 more
core  

Hazel (Corylus avellana L.) as a New Source of Taxol and Taxanes

Journal of Medicinal Plants, 2012
Taxol is used to treatment of variety cancers including ovarian, breast, lung, head and neck carcinomas and the AIDS-related Karposi’s carcinoma, and was originally obtained from bark of taxus brevifolia.
A Qaderi, M Omidi, A Etminan, A Oladzad, C Ebrahimi, MR Dehghani Mashkani, A Mehrafarin   +6 more
doaj  

Syntheses and Bioactivities of Targeted and Conformationally Restrained Taxol Analogs [PDF]

, 2004
Taxol (1) was first isolated from the bark of the Pacific yew about 35 years ago by Drs. Wall and Wani. Although its development as an anticancer agent was delayed by numerous reasons, including its scarcity and insolubility, the discovery of its tubulin-
Liu, Changhui
core  

Degradation kinetics of taxol using mass spectroscopy [PDF]

Paclitaxel is a very important anticancer drug commonly called Taxol®. We know from previous work (Hoffman, et al., 1998) that Taxol exists in filbert, Corylus avellana L. material.
Zhang, Jun
core   +1 more source

Over - expression Effect of Gene Encoding 3-hydroxy-3-Methylglutaryl-CoA Reductase on Production of Taxol in Iranian Hazel (Corylus avellana L.)

Journal of Medicinal Plants, 2013
Background: Sustainable and commercial production of taxol as an anti cancer drug is a critical point to its clinical application. Nowadays, hazel because of rapid growth and wide range distribution is considered as an alternative source of Taxol ...
A Qaderi, M Omidi, AR Zebarjadi, R Hajiaghaee   +3 more
doaj  

Cytoskeletal Regulation of Podosome-Focal Adhesion Balance in GM-CSF- and Flt3L-Derived Dendritic Cells. [PDF]

Cells
Biernacka Z, Gregorczyk-Zboroch K, Lasocka I, Bartak M, Gieryńska M, Struzik J, Toka FN, Szulc-Dąbrowska L.   +7 more
europepmc   +1 more source

Gender-Specific Behavior Reductions in Spontaneous Locomotive and Rearing in a Rat Model of Paclitaxel-Induced Peripheral Neuropathy: A Pilot Study. [PDF]

J Pain Res
Kim SJ, Cao K, Dougherty PM, McDonough KE, Javed S.   +4 more
europepmc   +1 more source

MATCAP1 preferentially binds an expanded tubulin conformation to generate detyrosinated and ΔC2 α-tubulin. [PDF]

EMBO J
Yue Y, Hotta T, Ohi R, Verhey KJ.
europepmc   +1 more source

Oscillatory dynamics in paclitaxel-proteinoid networks. [PDF]

Discov Mol
Mougkogiannis P, Adamatzky A.
europepmc   +1 more source

Recent paclitaxel formulation strategies: expanding the therapeutic index by addressing biopharmaceutical and toxicity limitations. [PDF]

Arch Pharm Res
Lee J, Choi MK, Song IS.
europepmc   +1 more source